Patients' evaluation of informed consent to postponed information: cohort study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Interventions for improving modifiable risk factor control in the secondary prevention of stroke.The Cochrane database of systematic reviews · 2018
   Pooled it
2. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.Trials · 2014
   Trial
3. Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT.BMC pulmonary medicine · 2009
   Trial
4. MR CLEAN-LATE, a multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in The Netherlands for late arrivals: study protocol for a randomized controlled trial.Trials · 2021
   Article
5. MR CLEAN-NO IV: intravenous treatment followed by endovascular treatment versus direct endovascular treatment for acute ischemic stroke caused by a proximal intracranial occlusion-study protocol for a randomized clinical trial.Trials · 2021
   Article
6. Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design.Trials · 2020
   Article
7. Local Management of Anogenital Warts in Non-immunocompromised Adults: A Systematic Review and Meta-analyses of Randomized Controlled Trials.Dermatology and therapy · 2019
   Article
8. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.BMC health services research · 2007
   Article
9. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.PLoS medicine · 2007
   Review
10. Solidarity: a (new) ethic for global health policy.Health care analysis : HCA : journal of health philosophy and policy · 2006
    Article
11. Deception in research on the placebo effect.PLoS medicine · 2005
    Article
12. Methodological reasons for not gaining prior informed consent are sometimes justified.BMJ (Clinical research ed.) · 2004
    Article

Corrections and comments

• Commented on by
  Methodological reasons for not gaining prior informed consent are sometimes justified.2004

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as